Navigation Links
Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
Date:2/9/2011

Alba Therapeutics.

About Larazotide Acetate and Celiac DiseaseCeliac disease is an autoimmune disorder that is triggered by the ingestion of gluten, which is primarily found in bread, pasta, cookies, pizza crust and other foods containing wheat, barley or rye. People with celiac disease who are exposed to gluten experience an immune reaction in their small intestines, causing damage to the inner surface (villi) of the small intestine, and an inability to absorb certain nutrients.  Signs and symptoms of celiac disease include intestinal pain, bloating, diarrhea and failure to thrive (infants and small children).  These symptoms can be reduced, and sometimes eliminated, by avoiding food that contains gluten.  However, many patients remain symptomatic despite a gluten-free diet, and these patients may benefit from the addition of pharmacotherapy.  

Larazotide acetate is a tight junction modulator.  Tight junctions in a normal bowel are closed except to shed dead cells.  In the presence of gluten in patients with celiac disease, these tight junctions remain open, thus starting an inflammatory cascade within the bowel that eventually destroys the intestinal villa.  Early research suggests larazotide acetate may help keep the tight junctions closed when ingested prior to a meal, thus reducing the inflammatory process in response to gluten.  

About Cephalon, Inc.Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells n
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImmunGene Announces Multi-Target R&D Collaboration With Cephalon Australia for Interferon Payload Technology
2. Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
3. Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
4. Cephalon to Webcast Investor Day
5. Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
6. Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations
7. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
8. Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
9. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
10. Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc.
11. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) today reported ... June 30, 2015 and updated its financial guidance for ... this morning, August 4, 2015, at 10:30 AM ET. ... by dialing (855) 582-8078. The conference ID is 90889796. ... revenues of $38.3 million, an increase of 118% as compared ...
(Date:8/3/2015)... Ill. , Aug. 3, 2015  Landauer, Inc. ... and environmental radiation measurement and monitoring, outsourced medical physics ... it will release financial results for the fiscal third ... 10, 2015. The Company will also ... 11, 2015 at 9:00 a.m. Central Time (10:00 a.m. ...
(Date:8/3/2015)... (Nasdaq: DRRX ) announced today financial results for the ... net loss was $5.5 million for the three months ended ... million and net loss of $5.5 million for the three ... cash and investments of $37.8 million, compared to cash and ... 30, 2015, we had $19.8 million in long term debt. ...
Breaking Medicine Technology:ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 2ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 4ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 5ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 6ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 7ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 8ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 9ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 10ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 11ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 12ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 13ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 14ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 15ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 16Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call 2DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 9DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 10
... deep regret, Adeona Pharmaceuticals, Inc. (Amex: AEN ... President of Research & Development, David A. Newsome, M.D. ... first person to pioneer and demonstrate the benefits of ... the leading cause of blindness in older Americans. Oral ...
... SHENZHEN, China, Feb. 25, 2011 /PRNewswire-Asia/ -- Tongjitang Chinese ... TCM ), announced that it has called an extraordinary ... at 10:00 a.m. (China time) on Thursday, March 31, ... B, Nanshan Medical Device Park, 1019 Nanhai Avenue, Nanshan ...
Cached Medicine Technology:Adeona Mourns the Passing of David A. Newsome, M.D., Senior Vice President of Research & Development 2Adeona Mourns the Passing of David A. Newsome, M.D., Senior Vice President of Research & Development 3Tongjitang Chinese Medicines Company Announces Extraordinary General Meeting of Shareholders 2Tongjitang Chinese Medicines Company Announces Extraordinary General Meeting of Shareholders 3
(Date:8/4/2015)... ... ... More than 700 years of marital bliss were celebrated as 13 couples from ... Shawn Kafader and Richard Oas lead the non-denominational service for married couples wishing to ... music by the Moonlight Serenade Orchestra and a special honeymoon dinner featuring lobster and ...
(Date:8/4/2015)... Texas (PRWEB) , ... August 04, 2015 , ... The ... in allegedly defective medical device lawsuit claims dealing with Inferior Vena Cava Filters (“IVC ... filing the firm’s federal cases for Cook IVC Filter clients under In re Cook ...
(Date:8/4/2015)... Coast, Florida (PRWEB) , ... August 04, 2015 ... ... Sankyo Inc have awarded independent educational grants in support of an interaction simulation ... and DVT/PE." The activity is jointly provided by Medical Learning Institute Inc. and ...
(Date:8/4/2015)... ... August 04, 2015 , ... Mr Didier Cauchois, ... impressive so far". , Mr Cauchois attributes the success to the dedication ... Dicma and the healthcare technology offered by Winscribe's platform. , "We have ...
(Date:8/3/2015)... ... 04, 2015 , ... The National Association of Professional ... the NAPW VIP Woman of the Year Circle. She is recognized with this ... 200 operating Local Chapters, NAPW is the nation’s leading networking organization exclusively for ...
Breaking Medicine News(10 mins):Health News:Couples Renew Vows at Friendship Village of Schaumburg 2Health News:Law Offices of Ben C. Martin in Dallas Files New IVC Filter Complications Lawsuits and Pursues Settlements 2Health News:Law Offices of Ben C. Martin in Dallas Files New IVC Filter Complications Lawsuits and Pursues Settlements 3Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 2Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 2Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 4Health News:National Association of Professional Women Inducts Armethia Holt, CEO at AA&G Group Homes, LLC, Into its VIP Woman of the Year Circle 2
... 22 The National Board of Certification for Medical ... exam that will be part of the testing for ... 300 interpreters will "test the test" designed to verify ... skills in real-life medical interpreting scenarios. This process will ...
... BEACH, Calif., May 22 Forterus Inc. (Pink Sheets: ... Treatment Center, Inc. in Murrieta, California, said today that ... be aired on the A & E Network at ... is a reality based TV series featuring people who ...
... Physican Offices Improve Practice Efficiency and Cash Flow , ... ... 2009-- Today MedicalBillingSoftware.com announced the availability of Medisoft® v15, the ... by more than 70,000 providers in small physician offices. With ...
... appointed to represent nurses worldwide in advancing the role of Telenursing. ... ... -- AMD Global Telemedicine Inc. announces Diane Castelli, RN, MS, MSN, ... Association,s (ATA) Telehealth Nursing Special Interest Group (SIG). Castelli will ...
... agencies have fallen to historic lows across the United States. Even the ... letter carriers, from over seven thousand in 1983, to less than three ... ... 2009 -- The National Canine Research Council says that when ...
... OMMA Healthcare, LLC and Medical Equipment Solutions International. ... OMMA,s Middle East division, OMMA Projects-Middle East, and ... Construction. The Governorate of Baghdad selected the team ... Al Nahrein Hospital, previously Al Rasheed Military Hospital, ...
Cached Medicine News:Health News:National Medical Interpreter Certification Testing Enters Pilot Phase 2Health News:National Medical Interpreter Certification Testing Enters Pilot Phase 3Health News:MedicalCharting.com Launches EMR Softwaret Solution with CCHIT-Certified EHR Software 2Health News:MedicalCharting.com Launches EMR Softwaret Solution with CCHIT-Certified EHR Software 3Health News:AMD Global Telemedicine Inc., Proud to Announce Diane Castelli, Chair of the American Telemedicine Association's (ATA) Telehealth Nursing Special Interest Group (SIG) 2Health News:A Dog's Eye View For Dog Bite Prevention 2Health News:A Dog's Eye View For Dog Bite Prevention 3Health News:An International Design Team has Been Selected for an Iraqi Hospital to Transform Healthcare in the Middle East 2
Fine & Medium Tapers....
Contour Design Eyelid Implants....
For Frontalis Suspension in patients with significant ptosis and poor levator function....
Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be easily drill...
Medicine Products: